{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:16:54Z","timestamp":1791487014531,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010815","name":"Foundation for Old Maids","doi-asserted-by":"publisher","award":["2023-125"],"award-info":[{"award-number":["2023-125"]}],"id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Foundation for Old Maids","doi-asserted-by":"publisher","award":["2023-109"],"award-info":[{"award-number":["2023-109"]}],"id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007137","name":"Northern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["HNF1540-20"],"award-info":[{"award-number":["HNF1540-20"]}],"id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2019-466-236"],"award-info":[{"award-number":["JPND2019-466-236"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["NRC 311993"],"award-info":[{"award-number":["NRC 311993"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2021-02680"],"award-info":[{"award-number":["2021-02680"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","award":["FoUI-987602"],"award-info":[{"award-number":["FoUI-987602"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018163","name":"Margareta af Ugglas Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018163","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun and Bertil Stohnes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010773","name":"Dementia Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebiom.2025.105598","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:32:13Z","timestamp":1740069133000},"page":"105598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-1430","authenticated-orcid":false,"given":"Robin Ziyue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gaunitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn-Eivind","family":"Kirsebom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka","family":"Jejcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sk\u00f6ldunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2143-7052","authenticated-orcid":false,"given":"Sophia","family":"Schedin-Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-4950","authenticated-orcid":false,"given":"Lars O.","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105598_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer's disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2025.105598_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2025.105598_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105598_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105598_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2025.105598_bib6","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","author":"Cummings","year":"2023","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2025.105598_bib7","article-title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease","volume":"9","author":"Honig","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.ebiom.2025.105598_bib9","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/brain\/awaa325","article-title":"Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics","volume":"143","author":"Tijms","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.105598_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2025.105598_bib11","series-title":"Essentials of Glycobiology","author":"Varki","year":"2022"},{"key":"10.1016\/j.ebiom.2025.105598_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease","volume":"7","author":"Kizuka","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2025.105598_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule\u2013associated protein tau: an abnormal posttranslational modification in Alzheimer's disease","volume":"2","author":"Wang","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105598_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4522(02)00510-9","article-title":"Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5","volume":"115","author":"Liu","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ebiom.2025.105598_bib15","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00018-020-03643-3","article-title":"Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration","volume":"78","author":"Losev","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2025.105598_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2018.05.126","article-title":"Glycosylation status of nicastrin influences catalytic activity and substrate preference of \u03b3-secretase","volume":"502","author":"Moniruzzaman","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ebiom.2025.105598_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jb\/mvac073","article-title":"The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2","volume":"172","author":"Shirotani","year":"2022","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.ebiom.2025.105598_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/glycob\/cwac009","article-title":"Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein","volume":"32","author":"Lin","year":"2022","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2025.105598_bib19","article-title":"Human brain glycoform coregulation network and glycan modification alterations in Alzheimer's disease","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2025.105598_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc5802","article-title":"Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2025.105598_bib21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/jnc.15202","article-title":"The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease","volume":"159","author":"Gaunitz","year":"2021","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ebiom.2025.105598_bib22","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1038\/s41598-023-34787-4","article-title":"Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease","volume":"13","author":"Tang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105598_bib23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/biom11060858","article-title":"What can N-glycomics and N-glycoproteomics of cerebrospinal fluid tell us about alzheimer disease?","volume":"11","author":"Gaunitz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ebiom.2025.105598_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jprot.2015.10.006","article-title":"CSF N-glycoproteomics for early diagnosis in Alzheimer's disease","volume":"131","author":"Palmigiano","year":"2016","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.ebiom.2025.105598_bib25","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1111\/febs.15197","article-title":"Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment","volume":"287","author":"Schedin-Weiss","year":"2020","journal-title":"FEBS J"},{"issue":"s1","key":"10.1016\/j.ebiom.2025.105598_bib26","first-page":"S93","article-title":"Bisecting N-acetylglucosamine correlates with phospho-Tau181 in subjective cognitive decline but not in control cases","volume":"100","author":"Egeb\u00e4ck","year":"2024","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2025.105598_bib27","first-page":"6","article-title":"A\u00a0glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients","volume":"18","author":"Zhou","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.ebiom.2025.105598_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","author":"Jack","year":"2024","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/alz.13528","article-title":"Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-\u03b2 positive individuals","volume":"20","author":"Woo","year":"2024","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2025.105598_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2025.105598_bib32","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","article-title":"Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2025.105598_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2010.44","article-title":"Ovarian cancer: the duplicity of CA125 measurement","volume":"7","author":"Karam","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2025.105598_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.765259","article-title":"Human brain and blood N-glycome profiling in Alzheimer's disease and Alzheimer's disease-related dementias","volume":"13","author":"Yu","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2025.105598_bib35","article-title":"Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N -glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism","volume":"14","author":"Tena","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib36","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/alz.13024","article-title":"A\u00a0glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status","volume":"19","author":"Zhou","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/rej.2009.0992","article-title":"Altered serum glycomics in Alzheimer disease: a potential blood biomarker?","volume":"13","author":"Chen","year":"2010","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.ebiom.2025.105598_bib38","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bbagen.2016.03.009","article-title":"Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery","volume":"1860","author":"Gizaw","year":"2016","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ebiom.2025.105598_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF03324546","article-title":"A\u00a0longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC)","volume":"16","author":"Lagergren","year":"2004","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.ebiom.2025.105598_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ageing\/afr084","article-title":"Human serum N-glycan profiles are age and sex dependent","volume":"40","author":"Ding","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.ebiom.2025.105598_bib41","first-page":"97","article-title":"Detecting at-risk Alzheimer's disease cases","volume":"60","author":"Fladby","year":"2017","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2025.105598_bib42","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.ebiom.2025.105598_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group\u2217 under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2025.105598_bib44","first-page":"637","article-title":"Clinical dementia rating (CDR)","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ebiom.2025.105598_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13854046.2019.1574902","article-title":"Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years","volume":"33","author":"Kirsebom","year":"2019","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.ebiom.2025.105598_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13854046.2020.1829068","article-title":"Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years","volume":"34","author":"Espenes","year":"2020","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.ebiom.2025.105598_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/23279095.2021.1918128","article-title":"Regression-based norms for the FAS phonemic fluency test for ages 40\u201384 based on a Norwegian sample","volume":"30","author":"Lorentzen","year":"2023","journal-title":"Appl Neuropsychol Adult"},{"key":"10.1016\/j.ebiom.2025.105598_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1037\/neu0000698","article-title":"Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia","volume":"34","author":"Eliassen","year":"2020","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ebiom.2025.105598_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1590\/S1980-57642009DN30200002","article-title":"The clock drawing test a review of its accuracy in screening for dementia","volume":"3","author":"Aprahamian","year":"2009","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.ebiom.2025.105598_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99794-9","article-title":"Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","volume":"11","author":"Siafarikas","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105598_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-023-02973-w","article-title":"Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease","volume":"20","author":"Nordengen","year":"2023","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.ebiom.2025.105598_bib52","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1039\/C9AN00486F","article-title":"Standardization of PGC-LC-MS-based glycomics for sample specific glycotyping","volume":"144","author":"Ashwood","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.ebiom.2025.105598_bib53","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1007\/s00216-022-04133-0","article-title":"Dextran as internal calibrant for N-glycan analysis by liquid chromatography coupled to ion mobility-mass spectrometry","volume":"414","author":"Manz","year":"2022","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.ebiom.2025.105598_bib54","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2025.105598_bib55","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/pr7008252","article-title":"GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans","volume":"7","author":"Ceroni","year":"2008","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.ebiom.2025.105598_bib56","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/glycob\/cwz045","article-title":"Updates to the symbol nomenclature for glycans guidelines","volume":"29","author":"Neelamegham","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2025.105598_bib57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/rcm.6527","article-title":"Tandem mass spectra of glycan substructures enable the multistage mass spectrometric identification of determinants on oligosaccharides","volume":"27","author":"Everest-Dass","year":"2013","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.ebiom.2025.105598_bib58","first-page":"3221","article-title":"Accelerating t-SNE using tree-based algorithms","volume":"15","author":"van der Maaten","year":"2014","journal-title":"J\u00a0Mach Learn Res"},{"key":"10.1016\/j.ebiom.2025.105598_bib59","series-title":"pheatmap: Pretty Heatmaps. R package version 1.0.12","author":"Kolde","year":"2018"},{"key":"10.1016\/j.ebiom.2025.105598_bib60","article-title":"Fitting linear mixed-effects models using lme 4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.ebiom.2025.105598_bib61","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.ebiom.2025.105598_bib62","series-title":"Readxl: read excel files","author":"Wickham","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105598_bib63","series-title":"tidyr: Tidy Messy Data. R package version 1.3.1","author":"Wickham","year":"2024"},{"key":"10.1016\/j.ebiom.2025.105598_bib64","series-title":"dplyr: a Grammar Of Data Manipulation. R package version 1.1.4","author":"Wickham","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105598_bib65","series-title":"ggplot 2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.ebiom.2025.105598_bib66","doi-asserted-by":"crossref","first-page":"772","DOI":"10.21105\/joss.00772","article-title":"ggeffects: Tidy data frames of marginal effects from regression models","volume":"3","author":"L\u00fcdecke","year":"2018","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.ebiom.2025.105598_bib67","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/glycob\/cwv091","article-title":"Symbol nomenclature for graphical representations of glycans","volume":"25","author":"Varki","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2025.105598_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601576","article-title":"Interplay between protein glycosylation pathways in Alzheimer's disease","volume":"3","author":"Frenkel-Pinter","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2025.105598_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.04.020","article-title":"Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila","volume":"56","author":"Frenkel-Pinter","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2025.105598_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12035-014-8695-8","article-title":"Endoplasmic reticulum dysfunction in Alzheimer's disease","volume":"51","author":"Li","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ebiom.2025.105598_bib71","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1320192111","article-title":"A\u03b2-induced Golgi fragmentation in Alzheimer's disease enhances A\u03b2 production","volume":"111","author":"Joshi","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2025.105598_bib72","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41380-022-01926-8","article-title":"Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer's disease through polygenic risk and RNA sequencing","volume":"28","author":"Crawford","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2025.105598_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib74","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.ebiom.2025.105598_bib75","series-title":"Analysis of N- and O-glycosylation of lysosomal glycoproteins","first-page":"35","author":"Tokhtaeva","year":"2017"},{"key":"10.1016\/j.ebiom.2025.105598_bib76","article-title":"Representativeness of samples enrolled in Alzheimer's disease research centers","volume":"15","author":"Arce Renter\u00eda","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect alzheimer disease in primary care and secondary care","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2025.105598_bib78","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","article-title":"Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2025.105598_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.1612","article-title":"Tau Positron emission tomography for predicting dementia in individuals with Mild cognitive impairment","author":"Groot","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2025.105598_bib81","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/acschemneuro.2c00057","article-title":"O-GlcNAcase inhibitor ASN90 is a multimodal drug candidate for tau and \u03b1-synuclein proteinopathies","volume":"13","author":"Permanne","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.ebiom.2025.105598_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109863","article-title":"DHEC mesylate attenuates pathologies and aberrant bisecting N-glycosylation in Alzheimer's disease models","volume":"248","author":"Wang","year":"2024","journal-title":"Neuropharmacology"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:19:01Z","timestamp":1762618741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S2352396425000428"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105598","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105598"}}